trinamiX Face Authentication by BASF

trinamiX Face Authentication is the first to be certified as highly secure behind OLED

The first face authentication to pass Android Biometric Security Test and FIDO Biometric Component Certification, while the hardware is mounted behind an OLED display
Solution officially approved for integration into Android phones as well as for use in particularly sensitive applications

trinamiX Face Authentication is the world’s first to fulfill highest biometric security demands while the hardware is invisibly mounted behind an OLED display. The solution was lately put to the thorough test of accredited assessment institutes. It was certified to be spoof-proof behind OLED according to the top standards defined by AndroidTM and FIDO® Alliance. trinamiX GmbH, a German subsidiary of BASF SE, is thus taking a further step towards creating the next generation of biometric authentication for smartphones. 

Cosmo Speciality Chemicals launches organic complexing agents

 Cosmo Speciality Chemicals, a 100% subsidiary of Cosmo Films Ltd., has launched a range of organic complexing agents – Sequest SA and Sequest DM. The agents are effective in hard water and exhibit excellent chelation properties over a wide range of pH. Applicable in pre-treatment, dyeing and printing processes like desizing, bleaching, dyeing and printing, both agents prevent the corrosion of the metal. Sequest SA is a highly effi cient, eco-friendly, high temperature stable sequestering agent for Ca+2, Fe+3 and other heavy metals; while Sequest DM is a high performance demineralising agent to remove heavy metal ions from cotton and process water. The two agents form complexes by reaction of their negatively charged donor groups with polyvalent metal ions like iron present on the greige fabric and in process water.

Source : chemical weekly 

MIDC relocate 150 manufacturing units from Dombivli to Patalganga

MIDC to relocate 156 manufacturing units from Dombivli to Patalganga

 The Maharashtra Industrial Development Corporation (MIDC) has taken a decision to relocate 156 chemicals, hazardous and high risk industries from Dombivli in Thane district to Patalganga in Raigad district. State Industry Minister, Mr. Subhash Desai made the announcement days after the MIDC Board gave its approval after accepting the survey of the Directorate of Industrial Safety and Health of these industries. “The decision to relocate the factory was taken after frequent accidents and pollution came to the fore. Dombivali Industrial Area has 525 industrial plots and there are 617 residential plots. 

The industrial units located at a distance of 50-m from residential areas, in particular, will be relocated to avoid possible accidents,” said Mr. Desai. He further added that MIDC will make an offer to convert these 156 units to engineering, information technology and non-polluting units and continue to operate on the existing plots. Mr. Desai added that units, which want to shift to Patalganga, will be provided plots to start their chemical units. “MIDC will make available lands in the Patalganga industrial estate,” he added. A MIDC offi cer said it has the list of 156 units adding that they will be approached soon on relocation to Patalganga or converting the existing chemical units into non-polluting units.

NJ Biopharmaceuticals expands facility in New Jersey

NJ Biopharmaceuticals, a leading provider of chemistry and biopharmaceutical services specialising in bioconjugation, custom synthesis, fl ow chemistry, and process development has expanded its footprint at its laboratory and headquarters at Princeton, New Jersey (USA) from 35,000 square feet to approximately 79,000 square feet. The expansion will include GMP manufacturing capabilities for bioconjugates and small molecules. With the expansion, NJ Bio will soon be able to support the development and GMP manufacturing of Antibody Drug Conjugates (ADCs) to meet the growing demand for clinical assets in this fi eld. NJ Bio is aggressively hiring synthetic organic, bioconjugation and oligonucleotide chemists as well as analytical and QA/QC personnel to increase capacity and build up its GMP manufacturing capabilities. 

NJ Bio will also continue to operate its facility in Bristol (Pennsylvania, USA) with plans to further expand its GMP manufacturing capabilities. Commenting on the development, Dr. Nareshkumar Jain, President and CEO of NJ Bio, said, “We are laser-focused on setting up our state-of-theart GMP manufacturing suites to become operational in 2022. 

This expansion will enable us to manufacture GMP grade payload-linkers, drug candidates, and antibody-drug conjugates for phase 1-3 clinical studies for our clients.” The company said the expansion of resources and facilities is an important step to transition from being a contract research provider to a contract development and manufacturing organisation (CDMO).

GranBio-Birla Carbon partnership for nanocellulose dispersion composite master batch

 Avapco, a subsidiary of Brazilian biotech fi rm, GranBio Technologies, has been awarded $500,000 in funding from P3Nano, a public-private partnership between the US Endowment for Forestry & Communities and the USDA Forest Service (USFS), along with an additional $230,000 from the USFS under a separate programme to advance scale-up and commercial introduction of the Nanocellulose Dispersion Composite (NDC) rubber masterbatch for the tyre and rubber goods markets. 

The breakthrough NDC masterbatch is the result of a four-year joint development program between Birla Carbon and GranBio, designed to address growing sustainability demands from the tyre industry in terms of improving both tyre rolling resistance and vehicle fuel economy through enabling the incorporation of sustainable, bio-derived nanocellulose into commercial rubber compounds. P3Nano’s funding programme targets projects designed to advance the commercialization of cellulosic nanomaterial's. 

Under the competitive award, the companies will demonstrate continuous scale-up of production of the NDC at GranBio’s biorefi nery in Thomaston, Georgia for anticipated full-scale factory and on-road tyre trials by global partners within the tyre and mechanical rubber goods industries. Under the additional competitive award from the USFS’s Wood Innovations programme, designed to expand and accelerate market growth for wood products, the companies will prepare an engineering package, market analysis, and fi nancial modelling for the fi rst NDC commercial plant. 

Mr. Bernardo Gradin, CEO of GranBio Technologies, said, “The NDC is a key example of GranBio’s mission to “Enable Net Zero” solutions through the development and deployment of sustainable biomass-based technologies across the biofuels, biochemicals, and advanced biomaterials sectors. The partnership with Birla Carbon materialises a common strategy to enable net-zero emission in tyres and the automotive value chain.”